Dietary fats

The "low-fat" decades produced a generation of confused eaters and roughly zero cardiovascular benefit. The contemporary evidence is more nuanced and more actionable: type matters more than amount, the substitution effect dominates outcomes (it matters enormously what replaces a removed fat), and the food matrix modulates the molecule. Industrial trans fats are unambiguously harmful and largely eliminated from regulated food supplies. Saturated fats are mixed — neutral in fermented dairy, problematic in fatty ruminant meat — and the replacement macronutrient determines the net effect on disease risk. Polyunsaturated fats (both omega-3 and, contrary to a popular framing, omega-6) are protective. Monounsaturated fats — chiefly extra-virgin olive oil — anchor the most-evidenced longevity diet on the planet. Dietary cholesterol from eggs is largely safe within sensible thresholds, with a striking geographic pattern that reflects the rest of the diet around them.

This article walks each fat class with the 2024–2026 evidence, including the recent epigenetic-clock work that quantifies the biological-age impact of each type in years.

The framework, briefly

Four practical rules organise almost all of the evidence:

Eliminate industrial trans fats. Non-negotiable. The molecule is biologically alien and the dose-response is steep.
Don't reduce saturated fat in isolation — substitute it. The benefit comes from what you put in instead. Polyunsaturated and monounsaturated fats win; refined carbohydrates don't.
Get adequate omega-3s. From fatty fish twice a week, or from a 1 g/day EPA+DHA supplement — see Omega-3.
The food matrix matters. Saturated fat in fermented dairy behaves differently from saturated fat in processed meat; cholesterol in whole eggs behaves differently from cholesterol in a Western brunch.

The rest of this article is the evidence behind those four lines.

Industrial trans fats — the one molecule to actually eliminate

Industrial trans fats, formed by the partial hydrogenation of vegetable oils, are the most metabolically deleterious dietary fat ever characterised. The trans double-bond geometry produces a rigid, linear molecule that mimics a saturated fat structurally but is biologically alien — disrupting endothelial function, lipid homeostasis, and DNA methylation.

The dose-response is sharp. A 1% increase in trans-fat energy associates with roughly 6% higher all-cause mortality and 6% higher cardiovascular mortality.^[1] Trans fats uniquely degrade the lipid profile in both directions simultaneously — raising LDL-C while suppressing HDL-C — and they accelerate the atherosclerotic cascade by upregulating ICAM-1, VCAM-1, and E-selectin on the vascular endothelium.

Newer epigenetic work has shown that trans-fat-enriched diets alter DNA methylation at the TNF (inflammatory cytokine) and ADIPOQ (adiponectin) loci within seven weeks of exposure in healthy young adults — a pre-clinical signature of cardiovascular pathology that precedes overt biomarker changes.^[2]

The good news is policy-driven. Between 1990 and 2021, the age-standardised mortality and disability burden attributable to high trans-fat intake fell by ~69% globally, driven by industrial-trans-fat bans in high-income regions.^[3] The FDA's final 2015 determination phased out partially hydrogenated oils in the US by 2018–2020; the EU's 2019/649 regulation capped industrial trans fats at 2 g per 100 g of fat from 2021. The residual exposure today is concentrated in unregulated markets and some legacy processed foods; reading ingredient labels for "partially hydrogenated oil" is still the reliable individual safeguard.

Naturally occurring (ruminant) trans fats — chiefly vaccenic acid and conjugated linoleic acid in dairy and meat — are biologically distinct from the industrial form and are not associated with cardiovascular harm at typical dietary intakes.

Saturated fat — the substitution effect dominates

Saturated fatty acids (SFAs) are where the 1980s consensus has been most heavily revised. The honest current reading: non-specific SFA reduction does little on its own; what matters is what replaces them.

Meta-analyses of randomised controlled trials reducing saturated fat without specifying a substitute show essentially null effects on all-cause mortality (RR ~1.01), cardiovascular mortality (RR ~0.94), and coronary events (RR ~0.85, not statistically significant).^[4] Reduction with explicit substitution tells a sharper story:

Substitution	Effect on cardiovascular disease
SFA → polyunsaturated fat (PUFA)	~30% risk reduction — similar effect size to statin primary prevention
SFA → monounsaturated fat (MUFA)	Moderate risk reduction
SFA → refined carbohydrates / added sugar	No benefit; insulin resistance and dyslipidemia worsen
Animal SFA → plant unsaturated fat (5% isocaloric shift)	~10% CVD risk reduction

That table is the 2017 AHA Presidential Advisory's central point, and it has held up across the subsequent decade of randomised and observational data.^[5]

The food matrix is doing real work

Not all saturated fat is biologically equivalent. SFAs from fermented dairy (yogurt, kefir, traditionally aged cheese) carry a neutral-to-mildly-protective cardiovascular signal in cohort meta-analyses; SFAs from fatty ruminant meats track consistently with higher CVD incidence.^[6] The reasons are physical and biochemical:

Fermented dairy delivers saturated fat embedded in a calcium-, vitamin-K2-, and bacterial-metabolite-rich matrix. The calcium-fatty-acid soap formation and the food-matrix architecture blunt LDL elevation that pure SFAs would produce.
Fatty meat delivers the same molecules without the matrix advantages — and with Neu5Gc, heme iron, TMAO precursors, and (when high-heat cooked) HCAs and PAHs. See Red and processed meat.

This is why "how much saturated fat?" is less informative than "saturated fat from what?".

The epigenetic-age signal

The strongest contemporary evidence on saturated fat and biological aging comes from NHANES-derived epigenetic-clock analyses. A doubling of total saturated-fat intake associates with a 0.42-year increase in GrimAge2, an epigenetic clock specifically trained to predict time to death.^[7] Specific fatty acids vary in effect:

Palmitic acid (16:0): +0.55 years of GrimAge2 per doubling — the most damaging single saturated species.
Stearic acid (18:0): +0.43 years per doubling.

A 2024 Mendelian randomization study using genetic instrumental variables found SFA intake causally and negatively associated with leukocyte telomere length (OR 0.80, 95% CI 0.70–0.91), confirming that the cohort signal isn't pure confounding.^[8]

The bottom line on saturated fat

Cap saturated fat at roughly 10% of total energy (the standard public-health threshold) — but spend most of your effort thinking about what replaces it. Olive oil and nuts are the highest-evidence substitutes. Refined carbohydrates are not. Fermented dairy is largely a wash. Fatty ruminant meat in volume is the form most worth limiting.

Polyunsaturated fats — the geroprotective class

Polyunsaturated fatty acids (PUFAs) — both omega-3 and omega-6 — are essential nutrients with the strongest aging-deceleration signal among dietary fats. The 2024–2026 epigenetic-clock work has put numbers on it.

Omega-3s: the strongest single epigenetic signal

The landmark DO-HEALTH trial, a 2,157-participant, three-year RCT in European seniors, tested 1 g/day of EPA+DHA omega-3 supplementation against multiple biological-age outcomes. Omega-3 independently slowed three of four next-generation DNA-methylation clocks (PhenoAge, GrimAge2, DunedinPACE), corresponding to roughly 2.9–3.8 months of biological age reduction over the three-year follow-up.^[9] The effect compounded additively when omega-3 was combined with regular exercise and vitamin D3 supplementation — the first time a nutritional supplement has produced a randomized epigenetic-aging readout in this magnitude.

Subtype-specific NHANES analyses extend the picture: a doubling of total PUFA intake associates with 0.59–0.68 years of decreased biological age across multiple clocks; alpha-linolenic acid (ALA, plant-derived 18:3) stands out at –0.69 years (PhenoAge); DHA (22:6) shows the broadest pan-tissue protective effect.^[10]

The mechanism runs through eicosanoid signalling, membrane fluidity, and PPARα-driven mitochondrial biogenesis. PUFAs are also direct substrates for specialized pro-resolving mediators (SPMs) — resolvins, protectins, maresins — that actively terminate inflammation rather than merely suppressing it.

If you eat fatty fish (salmon, sardines, mackerel, herring) twice a week, you're covered. If you don't, a 1 g/day EPA+DHA supplement is one of the few supplements with a randomized epigenetic-aging signal. The full discussion of doses, freshness, oxidation, and form is under Omega-3.

The "seed oil myth" — what the evidence actually says

The hypothesis that omega-6 linoleic acid (LA), the dominant PUFA in sunflower, safflower, soybean, canola, and corn oils, drives systemic inflammation and cardiovascular disease has become a popular online position. The 2024–2026 evidence resolutely disconfirms it.

A 2025 umbrella review pooling 150 cohort meta-analyses found that higher dietary intake and higher circulating omega-6 levels associate with lower risk of cardiovascular disease, several cancers, and all-cause mortality.^[11] Higher biomarker-confirmed linoleic acid intake associates with neutral-to-favourable cardiovascular outcomes; LA does not raise circulating inflammatory biomarkers in human RCTs.^[12] The AHA, Cochrane, and most national authorities all classify PUFA substitution for SFA as cardioprotective.

The remaining valid critiques of "seed oils":

Industrial deep-frying repeatedly heated oils (commercial fryers running for hours) produces oxidized lipid species that are measurably pro-inflammatory. The exposure issue here is real and is about cooking practice, not the molecule.
Refined oils are calorie-dense and show up alongside refined sugar, refined flour, and additives inside ultra-processed foods — and that surrounding matrix is what drives the harm, not the LA molecule per se. See Ultra-processed food.

The fixed reading: avoid ultra-processed foods that contain seed oils alongside refined sugar, refined flour, and additives. Avoid the deep-fried-at-the-commercial-chain category. Don't avoid linoleic acid in a home kitchen using fresh oil at moderate heat.

The omega-6 : omega-3 ratio

The two PUFA families compete for the same desaturase enzymes (especially Δ6-desaturase). When omega-6 vastly outnumbers omega-3 — as in the modern Western diet, often 15:1 or 20:1 — that competition skews eicosanoid metabolism toward a pro-inflammatory baseline. The UK Biobank analysis of 183,230 adults identified the circulating omega-6:omega-3 ratio as an independent mortality predictor; adding the ratio metric to the SCORE2 cardiovascular risk model improved prediction accuracy.^[13]

A reasonable target is between 1:1 and 4:1. You don't get there by avoiding linoleic acid — you get there by adding omega-3 (fatty fish twice a week or 1 g/day EPA+DHA), reducing ultra-processed food (which is omega-6-saturated), and using olive oil rather than corn or soybean oil as the primary cooking fat.

Monounsaturated fats and extra-virgin olive oil

Monounsaturated fatty acids (MUFAs), characterised by a single double bond and dominated dietarily by oleic acid, are the lipid backbone of the Mediterranean diet — the most-evidenced longevity dietary pattern by a comfortable margin. See Dietary patterns.

The headline trial: PREDIMED, a 7,447-participant Spanish randomised trial in adults at high cardiovascular risk, showed a ~30% reduction in major cardiovascular events in the Mediterranean-plus-EVOO and Mediterranean-plus-nuts arms versus a low-fat control, sustained over five years.^[14] An umbrella review of 31 meta-analyses confirmed that olive oil consumption associates with reduced cardiovascular disease, diabetes, and several cancers, with the strongest signal at the highest consumption quintile.^[15]

A Mendelian-randomization analysis found a causal positive association between circulating MUFA levels and preserved telomere length (OR 1.15, 95% CI 1.07–1.24).^[16] Extra-virgin olive oil also delivers a phenolic-compound payload (oleocanthal, hydroxytyrosol, oleuropein) that is anti-inflammatory and inhibits LDL oxidation independently of its fatty-acid content.

The clinically interesting nuance: in a head-to-head RCT, daily sunflower oil consumption (high in omega-6 PUFAs) actually lowered LDL-C by ~6 mg/dL versus EVOO's ~5 mg/dL increase — but sunflower-oil consumers showed modestly worse fasting insulin and peripheral insulin sensitivity.^[17] The cardiovascular benefit of EVOO is largest when it replaces saturated fat from animal sources, less compelling when displacing other already-healthy plant oils.

Avocado oil and nut oils are reasonable higher-heat alternatives with similar profiles. Other plant oils — canola, soybean — sit in the neutral middle: balanced MUFA/PUFA profiles, no harm signal in cohort data, less phenolic benefit than EVOO.

Dietary cholesterol and eggs

Eggs are the most-litigated single food in modern nutrition science. The current evidence permits a fairly specific reading.

The geographic paradox

Cohort outcomes for egg consumption differ sharply by population, in a way that maps cleanly onto the rest of the dietary pattern around them:^[18]

Population	Association with CVD per ~1 egg/day
US / Western cohorts	+8% relative risk (pooled RR 1.08, 95% CI 1.02–1.14)
European cohorts	Borderline positive (RR ~1.05)
Asian cohorts (Japan, general Chinese populations)	Neutral or protective (RR ~0.89, 95% CI 0.80–0.99)
Urbanised Chinese cohorts in nutritional transition	Elevated risk at very high intake

The simplest explanation: the companion foods are doing the work. In Western diets, an egg is typically eaten with bacon, sausage, refined-flour toast, and butter — a high-sodium, high-saturated-fat, ultra-processed meal. In a traditional Japanese diet, the same egg is eaten with rice, miso, fish, and vegetables. The egg molecule is identical; the matrix is not.

The non-linear threshold

Egg consumption shows a non-linear dose-response on mortality.^[19] Low to moderate intake (up to ~50 g/day, or one egg) does not elevate mortality risk in any major cohort. Statistically significant elevation begins only above ~75 g/day (1.5+ eggs per day). The American Heart Association's current position permits up to one egg per day within an otherwise healthy dietary pattern.

Why the lipid panel doesn't fully respond

When healthy adults eat extra eggs, the liver compensates: endogenous cholesterol synthesis is down-regulated. RCT meta-analyses show that each 100 mg/day increase in dietary cholesterol raises serum total cholesterol by only ~2.2–2.5 mg/dL, and the LDL:HDL ratio — the atherogenic metric — remains essentially stable.^[20] In an intervention study, Japanese adults adding one egg per day for four weeks actually improved HDL-C and reduced oxidised LDL — the egg's intrinsic antioxidant package (lutein, zeaxanthin, choline-phospholipids) protects rather than damages lipoprotein quality.

Phosphatidylcholine and the brain

Eggs are also the densest dietary source of phosphatidylcholine — the phospholipid that makes up roughly 30% of brain tissue lipid mass by weight and serves as the precursor to acetylcholine, the neurotransmitter most damaged in Alzheimer's. Choline delivered as egg-yolk phospholipid produces a ~4× higher plasma response than equivalent doses of synthetic choline bitartrate, with parallel increases in downstream metabolites betaine and dimethylglycine.^[21] Maintaining adequate plasma phosphatidylcholine through diet appears to preserve structural cognitive resilience in late life.

The bottom line on eggs

Whole eggs at up to 5–7 per week are compatible with most longevity-oriented dietary patterns for healthy adults. Eggs delivered alongside vegetables, whole grains, and unsaturated fats behave differently from eggs delivered alongside bacon, white toast, and processed cheese — and that's where the cohort heterogeneity comes from. The phosphatidylcholine and lutein/zeaxanthin payload is a useful side benefit.

Diabetics may warrant more caution; some cohort data show a stronger CVD association with eggs in established type 2 diabetes specifically.^[22]

Practical guidance

A defensible, evidence-aligned framework for fat quality:

Eliminate industrial trans fats. Read ingredient labels for "partially hydrogenated oil" or PHO. In regulated markets (US, EU, UK, most of Europe), residual exposure is now low; in unregulated markets the exposure can still be substantial.

Anchor on extra-virgin olive oil. EVOO is the highest-evidence single dietary fat. Use it as the default cooking and dressing oil. Avocado oil and nut oils are reasonable for high-heat cooking; canola, sunflower, and safflower are neutral.

Get omega-3s. Fatty fish twice a week or 1 g/day EPA+DHA. The DO-HEALTH epigenetic-clock signal is the strongest randomized geroprotective result in everyday supplementation. See Omega-3.

Don't fear linoleic acid in a home kitchen. Avoid the ultra-processed-food matrix and the commercial deep-fryer exposure, not the oil molecule.

Cap saturated fat near ~10% of energy — but spend more thought on the substitution. Replace it with PUFA or MUFA. Replacing it with refined carbohydrates produces no benefit.

Distinguish the food matrix. SFAs from fermented dairy are not equivalent to SFAs from processed or fatty meat. The matrix is doing real biological work.

Eggs: up to one per day is fine for most healthy adults. Pair them with vegetables and whole grains rather than bacon and refined-flour bread. Diabetics warrant a more conservative cap.

Aim for an omega-6:omega-3 ratio of 1:1 to 4:1. You achieve this by adding omega-3 and reducing ultra-processed food, not by hunting linoleic acid out of your kitchen.